| Date Filed | Type | Description |
| 07/07/2023 |
4
| O'Connor Daniel J. (President and CEO) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 1,216,500 options to buy
@ $0 |
|
| 05/12/2023 |
SC 13D/A
| O'Connor Daniel J. reports a 7.7% stake in ZyVersa Therapeutics, Inc. |
| 04/28/2023 |
4
| O'Connor Daniel J. (President and CEO) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 2,750,000 shares
@ $0 |
|
| 01/05/2023 |
4
| O'Connor Daniel J. (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.81, valued at
$40.5k
|
|
| 01/03/2023 |
3
| O'Connor Daniel J. (President and CEO) has filed a Form 3 on Ambrx Biopharma Inc. |
| 12/22/2022 |
SC 13D
| O'Connor Daniel J. reports a 16.8% stake in ZyVersa Therapeutics, Inc. |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| O'Connor Daniel J. (CEO) has filed a Form 4 on Larkspur Health Acquisition Corp.|
Txns:
| Acquired 42,005 shares
@ $0
Disposed of 23,404 options to buy
@ $0
Acquired 609 options to buy
@ $0 |
|
| 01/06/2022 |
4
| O'Connor Daniel J. (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 35,000 options to buy
@ $1.56, valued at
$54.6k
|
|
| 12/20/2021 |
3
| O'Connor Daniel J. (CEO) has filed a Form 3 on Larkspur Health Acquisition Corp. |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2020 |
4
| O'Connor Daniel J. (CEO and President) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Sold 3,280 shares
@ $3.79, valued at
$12.4k
|
|
| 08/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2020 |
4
| O'Connor Daniel J. (CEO and President) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Granted 90,580 shares
@ $0
Paid exercise price by delivering 44,471 shares
@ $2.23, valued at
$99.2k
Granted 304,000 options to buy
@ $1.56, valued at
$474.2k
|
|
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| O'Connor Daniel J. (CEO and President) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Sold 2,654 shares
@ $1.96, valued at
$5.2k
|
|
| 01/07/2020 |
4
| O'Connor Daniel J. (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 16,000 options to buy
@ $1.42, valued at
$22.7k
|
|
| 11/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2019 |
4
| O'Connor Daniel J. (CEO and President) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Paid exercise price by delivering 21,357 shares
@ $0.565, valued at
$12.1k
|
|
| 03/21/2019 |
4
| O'Connor Daniel J. (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 24,000 options to buy
@ $2.33, valued at
$55.9k
Granted 16,000 options to buy
@ $2.33, valued at
$37.3k
|
|
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/27/2018 |
4
| O'Connor Daniel J. (CEO and President) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Granted 750,000 shares
@ $0 |
|
| 11/07/2018 |
4
| O'Connor Daniel J. (CEO & President) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Bought 10,000 shares
@ $0.91, valued at
$9.1k
|
|
| 05/07/2018 |
4
| O'Connor Daniel J. (CEO) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Granted 250,000 options to buy
@ $1.47, valued at
$367.5k
|
|
| 02/06/2018 |
4
| O'Connor Daniel J. (CEO) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Bought 16,667 shares
@ $1.5, valued at
$25k
|
|
| 01/17/2018 |
4
| O'Connor Daniel J. (CEO) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Granted 2,000,000 options to buy
@ $0
Granted 500,000 options to buy
@ $0 |
|
| 09/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|